tiprankstipranks
Trending News
More News >
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market

Ascletis Pharma, Inc. (1672) Financial Statements

Compare
4 Followers

Ascletis Pharma, Inc. Financial Overview

Ascletis Pharma, Inc.'s market cap is currently HK$6.38B. The company's EPS TTM is HK$-0.1828934392; its P/E ratio is ―; Ascletis Pharma, Inc. is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.28M¥ 56.60M¥ 54.09M¥ 76.88M¥ 35.00M
Gross Profit¥ 735.00K¥ 25.99M¥ -24.69M¥ 39.17M¥ -23.50M
Operating Income¥ -403.40M¥ -306.81M¥ -262.82M¥ -195.90M¥ -156.43M
EBITDA¥ -390.58M¥ -126.09M¥ -284.50M¥ -169.35M¥ -181.94M
Net Income¥ -300.94M¥ -144.72M¥ -366.71M¥ -202.14M¥ -262.05M
Balance Sheet
Cash & Short-Term Investments¥ 1.95B¥ 2.30B¥ 2.48B¥ 2.50B¥ 2.71B
Total Assets¥ 2.12B¥ 2.49B¥ 2.66B¥ 2.83B¥ 3.07B
Total Debt¥ 7.63M¥ 8.42M¥ 4.24M¥ 2.75M¥ 1.59M
Net Debt¥ -858.10M¥ -321.70M¥ -2.47B¥ -2.49B¥ -2.71B
Total Liabilities¥ 158.41M¥ 148.94M¥ 117.16M¥ 100.89M¥ 85.42M
Stockholders' Equity¥ 1.97B¥ 2.34B¥ 2.54B¥ 2.73B¥ 2.98B
Cash Flow
Free Cash Flow¥ 0.00¥ -163.32M¥ -156.85M¥ -154.13M¥ -123.87M
Operating Cash Flow¥ 0.00¥ -144.16M¥ -142.45M¥ -146.93M¥ -84.91M
Investing Cash Flow¥ 0.00¥ 149.84M¥ -1.30B¥ -274.49M¥ 132.30M
Financing Cash Flow¥ 0.00¥ -81.50M¥ -1.42M¥ -31.10M¥ -21.67M
Currency in CNY

Ascletis Pharma, Inc. Earnings and Revenue History

Ascletis Pharma, Inc. Debt to Assets

Ascletis Pharma, Inc. Cash Flow

Ascletis Pharma, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis